Bone Tissue Collagen Maturity and Mineral Content Increase With Sustained Hyperglycemia in the KK-Ay Murine Model of Type 2 Diabetes

Overview

Journal J Bone Miner Res

Publisher Oxford University Press

Date 2017 Dec 28

PMID 29281127

Citations 21

Authors

Heather B Hunt

Jared C Pearl

David R Diaz

Karen B King

Eve Donnelly

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes mellitus (T2DM) increases fracture risk for a given bone mineral density (BMD), which suggests that T2DM changes bone tissue properties independently of bone mass. In this study, we assessed the effects of hyperglycemia on bone tissue compositional properties, enzymatic collagen crosslinks, and advanced glycation end-products (AGEs) in the KK-Ay murine model of T2DM using Fourier transform infrared (FTIR) imaging and high-performance liquid chromatography (HPLC). Compared to KK-aa littermate controls (n = 8), proximal femoral bone tissue of KK-Ay mice (n = 14) exhibited increased collagen maturity, increased mineral content, and less heterogeneous mineral properties. AGE accumulation assessed by the concentration of pentosidine, as well as the concentrations of the nonenzymatic crosslinks hydroxylysylpyridinoline (HP) and lysyl pyridinoline (LP), did not differ in the proximal femurs of KK-Ay mice compared to controls. The observed differences in tissue-level compositional properties in the KK-Ay mice are consistent with bone that is older and echo observations of reduced remodeling in T2DM. © 2017 American Society for Bone and Mineral Research.

Citing Articles

A Review of Animal Models for Studying Bone Health in Type-2 Diabetes Mellitus (T2DM) and Obesity.

Norazman S, Mohd Zaffarin A, Shuid A, Hassan H, Soleiman I, Kuan W Int J Mol Sci. 2024; 25(17).

PMID: 39273348 PMC: 11394783. DOI: 10.3390/ijms25179399.

Beyond bone volume: Understanding tissue-level quality in healing of maxillary vs. femoral defects.

Romanowicz G, Zhang L, Bolger M, Lynch M, Kohn D Acta Biomater. 2024; 187:409-421.

PMID: 39214162 PMC: 11890190. DOI: 10.1016/j.actbio.2024.08.042.

Metabolic and Skeletal Characterization of the KK/A Mouse Model-A Polygenic Mutation Model of Obese Type 2 Diabetes.

Chowdhury N, Surowiec R, Kohler R, Reul O, Segvich D, Wallace J Calcif Tissue Int. 2024; 114(6):638-649.

PMID: 38642089 PMC: 11184323. DOI: 10.1007/s00223-024-01216-1.

Utility and Limitations of TALLYHO/JngJ as a Model for Type 2 Diabetes-Induced Bone Disease.

Emini L, Salbach-Hirsch J, Krug J, Jahn-Rickert K, Busse B, Rauner M JBMR Plus. 2023; 7(12):e10843.

PMID: 38130754 PMC: 10731141. DOI: 10.1002/jbm4.10843.

Increased tissue modulus and hardness in the TallyHO mouse model of early onset type 2 diabetes mellitus.

Arora D, Taylor E, King K, Donnelly E PLoS One. 2023; 18(7):e0287825.

PMID: 37418415 PMC: 10328374. DOI: 10.1371/journal.pone.0287825.

References

Mercer N, Ahmed H, Etcheverry S, Vasta G, Cortizo A . Regulation of advanced glycation end product (AGE) receptors and apoptosis by AGEs in osteoblast-like cells. Mol Cell Biochem. 2007; 306(1-2):87-94. DOI: 10.1007/s11010-007-9557-8. View

Eyre D, Koob T, Van Ness K . Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem. 1984; 137(2):380-8. DOI: 10.1016/0003-2697(84)90101-5. View

Shu A, Yin M, Stein E, Cremers S, Dworakowski E, Ives R . Bone structure and turnover in type 2 diabetes mellitus. Osteoporos Int. 2011; 23(2):635-41. PMC: 3690650. DOI: 10.1007/s00198-011-1595-0. View

Boskey A, Mendelsohn R . Infrared analysis of bone in health and disease. J Biomed Opt. 2005; 10(3):031102. DOI: 10.1117/1.1922927. View

Vashishth D, Gibson G, Khoury J, Schaffler M, Kimura J, Fyhrie D . Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone. 2001; 28(2):195-201. DOI: 10.1016/s8756-3282(00)00434-8. View

Bank R, Beekman B, Verzijl N, de Roos J, Sakkee A, TeKoppele J . Sensitive fluorimetric quantitation of pyridinium and pentosidine crosslinks in biological samples in a single high-performance liquid chromatographic run. J Chromatogr B Biomed Sci Appl. 1998; 703(1-2):37-44. DOI: 10.1016/s0378-4347(97)00391-5. View

Katayama Y, Akatsu T, Yamamoto M, Kugai N, Nagata N . Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia. J Bone Miner Res. 1996; 11(7):931-7. DOI: 10.1002/jbmr.5650110709. View

Taketomi S, Tsuda M, Matsuo T, Iwatsuka H, SUZUOKI Z . Alterations of hepatic enzyme activities in KK and yellow KK mice with various diabetic states. Horm Metab Res. 1973; 5(5):333-9. DOI: 10.1055/s-0028-1093938. View

Gerdhem P, Isaksson A, Akesson K, Obrant K . Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int. 2005; 16(12):1506-12. DOI: 10.1007/s00198-005-1877-5. View

10.

Iwatsuka H, Shino A, SUZUOKI Z . General survey of diabetic features of yellow KK mice. Endocrinol Jpn. 1970; 17(1):23-35. DOI: 10.1507/endocrj1954.17.23. View

11.

Avery N, Bailey A . Enzymic and non-enzymic cross-linking mechanisms in relation to turnover of collagen: relevance to aging and exercise. Scand J Med Sci Sports. 2005; 15(4):231-40. DOI: 10.1111/j.1600-0838.2005.00464.x. View

12.

Paschalis E, Verdelis K, Doty S, Boskey A, Mendelsohn R, Yamauchi M . Spectroscopic characterization of collagen cross-links in bone. J Bone Miner Res. 2001; 16(10):1821-8. DOI: 10.1359/jbmr.2001.16.10.1821. View

13.

Odetti P, Rossi S, Monacelli F, Poggi A, Cirnigliaro M, Federici M . Advanced glycation end products and bone loss during aging. Ann N Y Acad Sci. 2005; 1043:710-7. DOI: 10.1196/annals.1333.082. View

14.

Farlay D, Armas L, Gineyts E, Akhter M, Recker R, Boivin G . Nonenzymatic Glycation and Degree of Mineralization Are Higher in Bone From Fractured Patients With Type 1 Diabetes Mellitus. J Bone Miner Res. 2015; 31(1):190-5. PMC: 4876148. DOI: 10.1002/jbmr.2607. View

15.

Pleshko N, Boskey A, Mendelsohn R . Novel infrared spectroscopic method for the determination of crystallinity of hydroxyapatite minerals. Biophys J. 1991; 60(4):786-93. PMC: 1260130. DOI: 10.1016/S0006-3495(91)82113-0. View

16.

Krakauer J, McKenna M, Buderer N, Rao D, WHITEHOUSE F, Parfitt A . Bone loss and bone turnover in diabetes. Diabetes. 1995; 44(7):775-82. DOI: 10.2337/diab.44.7.775. View

17.

Faibish D, Gomes A, Boivin G, Binderman I, Boskey A . Infrared imaging of calcified tissue in bone biopsies from adults with osteomalacia. Bone. 2005; 36(1):6-12. DOI: 10.1016/j.bone.2004.08.019. View

18.

Singh R, Barden A, Mori T, Beilin L . Advanced glycation end-products: a review. Diabetologia. 2001; 44(2):129-46. DOI: 10.1007/s001250051591. View

19.

Schaffler M, Cheung W, Majeska R, Kennedy O . Osteocytes: master orchestrators of bone. Calcif Tissue Int. 2013; 94(1):5-24. PMC: 3947191. DOI: 10.1007/s00223-013-9790-y. View

20.

Ou-Yang H, Paschalis E, Mayo W, Boskey A, Mendelsohn R . Infrared microscopic imaging of bone: spatial distribution of CO3(2-). J Bone Miner Res. 2001; 16(5):893-900. DOI: 10.1359/jbmr.2001.16.5.893. View